CMPS
Outside the watchlistCOMPASS Pathways plc
14.705
+0.65% (최근 종가 14.61)
Company Analysis
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- London, United Kingdom
- Employees
- 156
Company profile — from Yahoo Finance
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Company information as provided by Yahoo Finance. Check the official filings before relying on it.
Size · Range · Profitability
Market Cap
20억 달러
PER
-
Trailing 12 months
Forward P/E
-10.3배
Forward estimates
ROE
-319.1%
Return on equity
Dividend Yield
-
Beta
2.53
Volatility vs market
52주 범위에서 94% 지점입니다. 100%에 가까울수록 1년 최고가 부근입니다.
Source: Yahoo Finance
Wall Street Consensus
Average analyst price target
범위 $13.00 ~ $65.00 · 애널리스트 16명 · 종합의견 적극 매수 · 출처 Yahoo Finance
Analyst rating breakdown (2026-08-01)
월가는 이 종목을 뚜렷한 매수 우위로 보고 있습니다. (매수 22 · 관망 2 · 매도 0)
Annual Financials
Revenue trend
0억 달러
2022–2025 회계연도 · 축 단위는 달러입니다.
Net income trend
-3억 달러
2022–2025 회계연도 · 축 단위는 달러입니다.
| Year | Revenue | Operating Income | Net Income | Operating Cash Flow | Net Margin |
|---|---|---|---|---|---|
| 2025 | 0억 달러 | -2억 달러 | -3억 달러 | -2억 달러 | - |
| 2024 | 0억 달러 | -2억 달러 | -2억 달러 | -1억 달러 | - |
| 2023 | 0억 달러 | -1억 달러 | -1억 달러 | -1억 달러 | - |
| 2022 | 0억 달러 | -1억 달러 | -1억 달러 | -1억 달러 | - |
회계연도 기준 실적입니다(달력 연도와 다를 수 있습니다). 출처: Yahoo Finance. 값이 없는 항목은 채우지 않고 "-"로 둡니다.
SEC Filings (latest 3)
Related News (latest 3)
- Compass Pathways: There Are Different Scenarios To Be Considered In Clinical, Regulatory, And Commercialization↗
SeekingAlpha · 08. 25.
- Compass Pathways: Still A Buy, But The Exit Just Got Complicated↗
SeekingAlpha · 08. 25.
- Helus Pharma: An Undervalued Psychedelic Platform Approaching A Major Catalyst↗
SeekingAlpha · 08. 22.
What this ticker does not include
Prices, key stats, price targets, annual financials, filings and news above come straight from Yahoo Finance · Finnhub · SEC EDGAR, so they look the same for any US-listed ticker.
Support & resistance shows above whenever my TradingView indicator is sending alerts for the ticker. No alert is set up for this one yet, so there are no levels.
Option levels · MJM Score · REAL_BUY signals come through a Google Sheet and are still limited to the fixed watchlist. We leave them out rather than guess.